GI Windows
Private Company
Total funding raised: $45M
Overview
GI Windows is a private, clinical-stage medical device company engineering a paradigm-shifting magnetic anastomosis system for gastrointestinal bypass and reconstructive surgeries. Its core technology uses magnets to create a patent connection between hollow organs, demonstrating ease of use and improved healing in preclinical models and early human studies. The company is led by a seasoned team with deep experience in commercializing GI devices and is backed by strategic healthcare investors like Rex Health Ventures, positioning it to address a large, established surgical market with a novel, minimally invasive solution.
Technology Platform
Magnetic compression anastomosis (MCA) system for creating patent, sutureless/stapless connections between hollow organs in the GI tract via minimally invasive deployment of paired magnetic rings.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
GI Windows competes in the surgical anastomosis market, which is dominated by large medical device companies like Medtronic and Johnson & Johnson that offer mechanical staplers and sutures. Its primary competition is the entrenched standard of care. Other companies are exploring alternative anastomosis technologies, but GI Windows appears to be a leader in magnetic compression anastomosis for GI applications, with recent first-in-human data.